Press release
Vascular Stent Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG
Vascular Stent Market Characteristics
The Business Research Company offers in-depth market insights through Vascular Stent Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The vascular stent market size has grown rapidly in recent years. It will grow from $14.74 billion in 2023 to $16.26 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to clinical research and development, drug-eluting stents (des), introduction of balloon angioplasty, early stent innovations, physician training and skill development..
The vascular stent market size is expected to see strong growth in the next few years. It will grow to $23.61 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to focus on preventive cardiovascular care, shift towards outpatient procedures, cost-effectiveness and value-based healthcare, bioabsorbable stents and next-generation materials, expansion of endovascular interventions.. Major trends in the forecast period include advancements in stent coatings and materials, patient education and awareness, shift towards outpatient settings, focus on cost-effectiveness..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8363&type=smp
Market Segmentation:
The vascular stent market covered in this report is segmented -
1) By Product: Coronary Stents, Peripheral Vascular Stents, Evar Stent Grafts
2) By Type: Bare Metal Stent, Bio-engineered Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent, Dual Therapy Stent
3) By Material: Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Polymers Stents
4) By Mode of Delivery: Balloon-expandable Stent, Self-expanding Stent
5) By End-user: Ambulatory Surgical Center, Cardiac Center, Hospital
Major Driver - Navigating Cardiovascular Health Surge In Vascular Diseases Propels Growth Of The Vascular Stent Market
Rise in the incidence of vascular diseases will propel the growth of the vascular stent market going forward. Vascular disease refers to an abnormal condition that affects the blood vessels (arteries and veins) and is part of the cardiovascular diseases (CVD) group. Vascular stents help in the treatment of various vascular diseases by enabling the supply of oxygen-rich blood to the heart. For instance, in May 2023, according to the Center for Disease Control and Prevention, a US-based federal agency for national public health, about 695,000 people in the United States died from heart disease in 2021, that's 1 in every 5 deaths. Therefore, an increase in cardiovascular diseases (CVDs) will drive the growth of the vascular stent market.
Competitive Landscape:
Major companies operating in the vascular stent market report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., Lombard Medical Technologies Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology (Beijing) Co. Ltd., Koninklijke Philips N.V., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Stryker Corporation, Osypka AG, Spectranetics Corporation, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., Siemens Healthineers AG, General Electric Company, Nihon Kohden Corporation, Fujifilm Corporation, EP Medsystems Inc., ZOLL Medical Corporation
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report
Top Trend - Translumina's Vivo Isar Sets The Pace In The Technologically Advanced Vascular Stent Market
Technological advancement is a key trend gaining popularity in the vascular stent market. Many companies are investing in bio-sensing devices, cutting-edge integrated stents, and drug-eluting coronary stent systems to gain a competitive edge in the market. For instance, in 2022, Translumina, an India-based medical equipment manufacturer launched VIVO ISAR, a latest generation dual drug polymer-free coated stent (DDCS) that brings together a stent with a superior safety profile without compromising the drug release kinetics. It uses Probucol, an antioxidant and lipid-lowering drug, as a carrier for releasing Sirolimus (an anti-restenosis drug), and thus creates a polymer-free DES platform with uncompromised safety and efficacy.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Vascular Stent Market Characteristics
3. Vascular Stent Market Trends And Strategies
4. Vascular Stent Market - Macro Economic Scenario
5. Vascular Stent Market Size And Growth
…..
27. Vascular Stent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vascular Stent Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG here
News-ID: 3423799 • Views: …
More Releases from The Business research company
Leading Companies Fueling Growth and Innovation in the Automotive Solenoid Marke …
The automotive solenoid market is on the verge of significant expansion as advancements in technology and vehicle electrification continue to accelerate. Increasing integration of smart systems and the growing demand for efficient, eco-friendly automotive solutions are set to drive this market's development through the end of the decade.
Expected Growth Trajectory for the Automotive Solenoid Market by 2030
The automotive solenoid market is projected to reach a valuation of $7.81 billion…
Automotive Night Vision System Market Analysis: Major Segments, Strategic Develo …
The automotive night vision system market is set to experience significant expansion over the coming years, driven by technological advancements and growing safety demands. As vehicle manufacturers continue to integrate more sophisticated safety features, this market shows promising potential for rapid growth and innovation through 2030.
Projected Expansion of the Automotive Night Vision System Market Size Through 2030
The market size for automotive night vision systems is anticipated to reach $7.24…
Segment Analysis and Major Growth Areas in the Automotive HVAC Market
The automotive HVAC market is on a trajectory of significant growth as vehicle climate control systems evolve with advanced technologies. Innovations aimed at improving energy efficiency and passenger comfort are driving the sector forward, setting the stage for substantial expansion through 2030. Let's explore the current market size, key players, influential trends, and detailed segment insights shaping this dynamic industry.
Automotive HVAC Market Size and Growth Outlook Through 2030
The automotive…
Key Strategic Developments and Emerging Changes Shaping the Automotive Electroni …
The automotive electronic controller market is on track for impressive expansion as technology continues to transform the automotive sector. With the industry embracing smarter and more connected vehicle systems, the demand for advanced controllers that manage and optimize vehicle functions is rapidly increasing. Below, we explore the market's projected growth, key players, notable trends, and the main segments shaping this dynamic field.
Projected Market Size and Growth of the Automotive Electronic…
More Releases for Stent
Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What is the Airway Stent/Lung Stent Market and Why is It Significant?
The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,…
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
